Leadership. Knowledge. Community. Antiplatelet Therapy for the Primary Prevention of Vascular Events Working Group: Alan D. Bell, MD, CCFP and James D.
ASA - Is there a Primary Prevent Indication in Diabetes? Contemporary Therapeutic Issues in Cardiovascular Disease Saturday, May 8 th, 2010 Patrick Robertson,
Can we safely discharge TIA patients? Louis Muller EM Registrar January 2010.
Guidelines for the prevention of stroke in ischemic stroke and tia 2011
Stroke-2015-Kwok-1014-23
Leadership. Knowledge. Community. Antiplatelet Therapy for the Secondary Prevention of Cerebrovascular Disease Working Group: Ashfaq Shuaib, MD, FRCP;
Leadership. Knowledge. Community. USE OF ANTIPLATELET THERAPY IN PATIENTS WITH DIABETES Working Group: Maria E. Wolfs, MD, FRCP; Rémi Rabasa-Lhoret, MD,
Update of TARGET ( T reatment a nd R elief of G astroint e s t inal disorder)
